Com. Kessler resignation may bode well for FDA reform activity in 1997.
This article was originally published in The Rose Sheet
Executive Summary
FDA REFORM LEGISLATION MAY BE MORE FEASIBLE WITH KESSLER RESIGNATION: Commissioner David Kessler's Nov. 25 announcement that he plans to resign increases the likelihood that the Administration will forward its own FDA reform legislative proposal in 1997. Congress also has indicated that it plans to address FDA reform during the 105th session.